44 results
8-K
EX-99.1
THER
Theralink Technologies, Inc.
29 Sep 20
Theralink® Technologies Appoints Thomas Chilcott as Chief Financial Officer
4:05pm
and leading the accounting and finance department including all SEC filings. Additionally, Mr. Chilcott, a CPA, was the President of Chilcott Consulting
NT 10-Q
THER
Theralink Technologies, Inc.
17 May 22
Notice of late quarterly filing
9:00am
staffing interruptions due to turnover within the accounting department which have prevented the Company’s management from completing the financial
8-K
EX-10.5
THER
Theralink Technologies, Inc.
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
Commission (“EEOC”), Department of Labor (“DOL”), National Labor Relations Board (“NLRB”), the Financial Industry Regulatory Authority (“FINRA”), or the U.S … similar federal, state, or local department or agency. You shall promptly provide written notice of any such order to an authorized officer
8-K
THER
Theralink Technologies, Inc.
21 Aug 08
Changes in Control of Registrant
12:00am
by the US Department of Agriculture Forest Service. We have received no indication that the area will be withdrawn from mineral exploration … of Land Management, but within lands administered by the US Department of Agriculture Forest Service. During 1998, a Plan of Operation on the claims
8-K
EX-10.1
THER
Theralink Technologies, Inc.
14 Sep 11
PediatRx enters U.S. co-promotion agreement for AQUORALTM
12:00am
of the Product submitted to or received from the U.S. Department of Health and Human Services or its components (including the FDA and the Office of the Inspector
8-K
EX-10.2
yymj62h hr
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-10.4
qcf5puo14zi2 jaea89
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-10.1
tef3isrczig9z
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
425
EX-2.1
tej gc2ty
26 May 23
Business combination disclosure
5:14pm
8-K
EX-2.1
47gioe
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
EX-3.3
c5rmhu2u3
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-10.10
i84m47kk64lz4zf8l3i
28 Jul 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.4
d5d56rfyqloj9zcsm
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K/A
EX-10.2
ll7un2s 2rlmno4y7
21 Feb 19
Financial Statements and Exhibits
5:14pm